Skip to main content
See every side of every news story
Published loading...Updated

Siemens, Merck seek drug production breakthrough

Science and technology company Merck Group and Siemens went deeper on a longstanding partnership with plans to turn an eye to developing software, systems and consumable items to aid in drug production. A memorandum of understanding involves commitments to employ automation, data and AI to advance the discovery of new drugs, and then develop and produce them. Siemens and Merck hope their digital-first approach will close gaps in the processes be…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

6 Articles

Through a memorandum of understanding, Merck KGaA and Siemens deepened their collaboration in life sciences with the aim of accelerating drug development. The alliance seeks to integrate Artificial Intelligence (IA), automation and advanced data management to connect more fluidly all stages of a drug’s life cycle, from discovery to production. Given that the cost of drug development and manufacture is doubled in a very short time, companies want…

Merck and Siemens have deepened their strategic partnership with a new memorandum of understanding to accelerate digital transformation in the life sciences industry. The memorandum of understanding (MoU) focuses on the development of integrated software solutions based on automation...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Mobile World Live broke the news in on Tuesday, September 23, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal